BRIDGEWAY CAPITAL MANAGEMENT, LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 1 filers reported holding IMMUNE DESIGN CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$248,000
+350.9%
42,4000.0%0.00%
+200.0%
Q4 2018$55,000
-92.8%
42,400
-80.8%
0.00%
-85.7%
Q3 2018$763,000
+106.2%
221,192
+172.1%
0.01%
+75.0%
Q2 2018$370,000
-34.0%
81,292
-52.2%
0.00%
-33.3%
Q1 2018$561,000
+24.9%
170,000
+47.8%
0.01%
+20.0%
Q4 2017$449,000
-62.9%
115,000
-1.5%
0.01%
-64.3%
Q3 2017$1,209,000
+7.9%
116,800
+1.6%
0.01%0.0%
Q2 2017$1,121,000
+43.4%
115,0000.0%0.01%
+55.6%
Q1 2017$782,000
+23.5%
115,0000.0%0.01%
+12.5%
Q4 2016$633,000
-27.4%
115,0000.0%0.01%
-38.5%
Q3 2016$872,000115,0000.01%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2019
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders